What is PraXsyn Corporation?
PraXsyn Corporation, formerly The PAWS Pet Company, Inc., is a Las Vegas-based healthcare entity focused on formulating and distributing non-narcotic, non-habit forming medications. The company utilizes therapeutic and preventative agents in transdermal creams, patches, and oral capsules, targeting conditions such as pain management, erectile dysfunction, and metabolic therapies. PraXsyn Corporation primarily serves patients within the California workers compensation system and through preferred provider contracts, demonstrating a strategic focus on accessible healthcare solutions.
How much funding has PraXsyn Corporation raised?
PraXsyn Corporation has raised a total of $500K across 1 funding round:
Private Equity
$500K
Private Equity (2011): $500K, investors not publicly disclosed
What's next for PraXsyn Corporation?
The recent major strategic investment signifies a pivotal moment for PraXsyn Corporation, likely enabling the company to scale its manufacturing capabilities, broaden its distribution network, and potentially invest further in research and development for its innovative medication formulations. This enterprise-level backing suggests confidence from investors in PraXsyn's business model and its capacity to capture a larger share of the pain management and therapeutic markets, particularly within its established service areas.
See full PraXsyn Corporation company page
